Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Studies have demonstrated that polymorphic variants of arginase 1 gene (<i>ARG1</i>) are involved in human diseases, such as coronary heart disease, hypertension, and diabetes. Our study aimed to investigate the association between <i>ARG1</i> rs2781666 single nucleotide poly...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Monika Buraczynska, Izabela Zakrocka
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/23a6679ea2ac485587107b8f03fa1771
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23a6679ea2ac485587107b8f03fa1771
record_format dspace
spelling oai:doaj.org-article:23a6679ea2ac485587107b8f03fa17712021-11-25T18:02:30ZArginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients10.3390/jcm102254072077-0383https://doaj.org/article/23a6679ea2ac485587107b8f03fa17712021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5407https://doaj.org/toc/2077-0383Studies have demonstrated that polymorphic variants of arginase 1 gene (<i>ARG1</i>) are involved in human diseases, such as coronary heart disease, hypertension, and diabetes. Our study aimed to investigate the association between <i>ARG1</i> rs2781666 single nucleotide polymorphism (SNP) and diabetic retinopathy (DR) in type 2 diabetes (T2DM) patients. Polymorphism was genotyped in 740 T2DM patients and 400 healthy individuals. A significant difference in the genotype distribution was observed between the patients and the controls. The T allele and TT genotype were associated with an increased risk of T2DM (OR 1.4, 95% CI 1.14–1.72, <i>p</i> = 0.001 and OR 2.16, 95% CI 1.23–3.80, <i>p</i> = 0.007, respectively). When the T2DM subjects were stratified into DR+ and DR− subgroups, the T allele and TT genotype frequencies were significantly higher in the DR+ group compared to the DR− group, demonstrating OR 1.68 (1.33–2.12), <i>p</i> < 0.0001 and OR 2.39 (1.36–4.18), <i>p</i> = 0.002, respectively. Logistic regression analysis was applied to determine the interaction between the <i>ARG1</i> genotypes and other risk factors. Only <i>ARG1</i> rs2781666 SNP was a significant risk predictor of DR (<i>p</i> = 0.003). In conclusion, this is the first report discussing the effect of <i>ARG1</i> polymorphism on the microvascular complications that are associated with diabetes. Our findings demonstrate that <i>ARG1</i> rs2781666 SNP is significantly associated with an increased susceptibility to DR in T2DM patients.Monika BuraczynskaIzabela ZakrockaMDPI AGarticlearginase 1diabetic retinopathysingle nucleotide polymorphismrs2781666genotypingMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5407, p 5407 (2021)
institution DOAJ
collection DOAJ
language EN
topic arginase 1
diabetic retinopathy
single nucleotide polymorphism
rs2781666
genotyping
Medicine
R
spellingShingle arginase 1
diabetic retinopathy
single nucleotide polymorphism
rs2781666
genotyping
Medicine
R
Monika Buraczynska
Izabela Zakrocka
Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
description Studies have demonstrated that polymorphic variants of arginase 1 gene (<i>ARG1</i>) are involved in human diseases, such as coronary heart disease, hypertension, and diabetes. Our study aimed to investigate the association between <i>ARG1</i> rs2781666 single nucleotide polymorphism (SNP) and diabetic retinopathy (DR) in type 2 diabetes (T2DM) patients. Polymorphism was genotyped in 740 T2DM patients and 400 healthy individuals. A significant difference in the genotype distribution was observed between the patients and the controls. The T allele and TT genotype were associated with an increased risk of T2DM (OR 1.4, 95% CI 1.14–1.72, <i>p</i> = 0.001 and OR 2.16, 95% CI 1.23–3.80, <i>p</i> = 0.007, respectively). When the T2DM subjects were stratified into DR+ and DR− subgroups, the T allele and TT genotype frequencies were significantly higher in the DR+ group compared to the DR− group, demonstrating OR 1.68 (1.33–2.12), <i>p</i> < 0.0001 and OR 2.39 (1.36–4.18), <i>p</i> = 0.002, respectively. Logistic regression analysis was applied to determine the interaction between the <i>ARG1</i> genotypes and other risk factors. Only <i>ARG1</i> rs2781666 SNP was a significant risk predictor of DR (<i>p</i> = 0.003). In conclusion, this is the first report discussing the effect of <i>ARG1</i> polymorphism on the microvascular complications that are associated with diabetes. Our findings demonstrate that <i>ARG1</i> rs2781666 SNP is significantly associated with an increased susceptibility to DR in T2DM patients.
format article
author Monika Buraczynska
Izabela Zakrocka
author_facet Monika Buraczynska
Izabela Zakrocka
author_sort Monika Buraczynska
title Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
title_short Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
title_full Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
title_fullStr Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
title_full_unstemmed Arginase Gene Polymorphism Increases Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
title_sort arginase gene polymorphism increases risk of diabetic retinopathy in type 2 diabetes mellitus patients
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/23a6679ea2ac485587107b8f03fa1771
work_keys_str_mv AT monikaburaczynska arginasegenepolymorphismincreasesriskofdiabeticretinopathyintype2diabetesmellituspatients
AT izabelazakrocka arginasegenepolymorphismincreasesriskofdiabeticretinopathyintype2diabetesmellituspatients
_version_ 1718411667918815232